Efficacy of Three Low-Intensity, Internet-Based Psychological Interventions for the Treatment of Depression in Primary Care: Randomized Controlled Trial.


Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
05 06 2020
Historique:
received: 12 09 2019
accepted: 04 02 2020
revised: 03 12 2019
entrez: 6 6 2020
pubmed: 6 6 2020
medline: 15 12 2020
Statut: epublish

Résumé

Primary care is a major access point for the initial treatment of depression, but the management of these patients is far from optimal. The lack of time in primary care is one of the major difficulties for the delivery of evidence-based psychotherapy. During the last decade, research has focused on the development of brief psychotherapy and cost-effective internet-based interventions mostly based on cognitive behavioral therapy (CBT). Very little research has focused on alternative methods of treatment for depression using CBT. Thus, there is a need for research into other therapeutic approaches. This study aimed to assess the effectiveness of 3 low-intensity, internet-based psychological interventions (healthy lifestyle psychoeducational program [HLP], focused program on positive affect promotion [PAPP], and brief intervention based on mindfulness [MP]) compared with a control condition (improved treatment as usual [iTAU]). A multicenter, 4-arm, parallel randomized controlled trial was conducted between March 2015 and March 2016, with a follow-up of 12 months. In total, 221 adults with mild or moderate major depression were recruited in primary care settings from 3 Spanish regions. Patients were randomly distributed to iTAU (n=57), HLP (n=54), PAPP (n=56), and MP (n=54). All patients received iTAU from their general practitioners. The main outcome was the Spanish version of the Patient Health Questionnaire-9 (PHQ-9) from pretreatment (time 1) to posttreatment (time 2) and up to 6 (time 3) and 12 (time 4) months' follow-up. Secondary outcomes included the visual analog scale of the EuroQol, the Short-Form Health Survey (SF-12), the Positive and Negative Affect Schedule (PANAS), and the Pemberton Happiness Index (PHI). We conducted regression models to estimate outcome differences along study stages. A moderate decrease was detected in PHQ-9 scores from HLP (β=-3.05; P=.01) and MP (β=-3.00; P=.01) compared with iTAU at posttreatment. There were significant differences between all intervention groups and iTAU in physical SF-12 scores at 6 months after treatment. Regarding well-being, MP and PAPP reported better PHI results than iTAU at 6 months post treatment. PAPP intervention significantly decreased PANAS negative affect scores compared with iTAU 12 months after treatment. The low-intensity, internet-based psychological interventions (HLP and MP) for the treatment of depression in primary care are more effective than iTAU at posttreatment. Moreover, all low-intensity psychological interventions are also effective in improving medium- and long-term quality of life. PAPP is effective for improving health-related quality of life, negative affect, and well-being in patients with depression. Nevertheless, it is important to examine possible reasons that could be implicated for PAPP not being effective in reducing depressive symptomatology; in addition, more research is still needed to assess the cost-effectiveness analysis of these interventions. ISRCTN Registry ISRCTN82388279; http://www.isrctn.com/ISRCTN82388279. RR2-10.1186/s12888-015-0475-0.

Sections du résumé

BACKGROUND
Primary care is a major access point for the initial treatment of depression, but the management of these patients is far from optimal. The lack of time in primary care is one of the major difficulties for the delivery of evidence-based psychotherapy. During the last decade, research has focused on the development of brief psychotherapy and cost-effective internet-based interventions mostly based on cognitive behavioral therapy (CBT). Very little research has focused on alternative methods of treatment for depression using CBT. Thus, there is a need for research into other therapeutic approaches.
OBJECTIVE
This study aimed to assess the effectiveness of 3 low-intensity, internet-based psychological interventions (healthy lifestyle psychoeducational program [HLP], focused program on positive affect promotion [PAPP], and brief intervention based on mindfulness [MP]) compared with a control condition (improved treatment as usual [iTAU]).
METHODS
A multicenter, 4-arm, parallel randomized controlled trial was conducted between March 2015 and March 2016, with a follow-up of 12 months. In total, 221 adults with mild or moderate major depression were recruited in primary care settings from 3 Spanish regions. Patients were randomly distributed to iTAU (n=57), HLP (n=54), PAPP (n=56), and MP (n=54). All patients received iTAU from their general practitioners. The main outcome was the Spanish version of the Patient Health Questionnaire-9 (PHQ-9) from pretreatment (time 1) to posttreatment (time 2) and up to 6 (time 3) and 12 (time 4) months' follow-up. Secondary outcomes included the visual analog scale of the EuroQol, the Short-Form Health Survey (SF-12), the Positive and Negative Affect Schedule (PANAS), and the Pemberton Happiness Index (PHI). We conducted regression models to estimate outcome differences along study stages.
RESULTS
A moderate decrease was detected in PHQ-9 scores from HLP (β=-3.05; P=.01) and MP (β=-3.00; P=.01) compared with iTAU at posttreatment. There were significant differences between all intervention groups and iTAU in physical SF-12 scores at 6 months after treatment. Regarding well-being, MP and PAPP reported better PHI results than iTAU at 6 months post treatment. PAPP intervention significantly decreased PANAS negative affect scores compared with iTAU 12 months after treatment.
CONCLUSIONS
The low-intensity, internet-based psychological interventions (HLP and MP) for the treatment of depression in primary care are more effective than iTAU at posttreatment. Moreover, all low-intensity psychological interventions are also effective in improving medium- and long-term quality of life. PAPP is effective for improving health-related quality of life, negative affect, and well-being in patients with depression. Nevertheless, it is important to examine possible reasons that could be implicated for PAPP not being effective in reducing depressive symptomatology; in addition, more research is still needed to assess the cost-effectiveness analysis of these interventions.
TRIAL REGISTRATION
ISRCTN Registry ISRCTN82388279; http://www.isrctn.com/ISRCTN82388279.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)
RR2-10.1186/s12888-015-0475-0.

Identifiants

pubmed: 32501276
pii: v22i6e15845
doi: 10.2196/15845
pmc: PMC7305559
doi:

Banques de données

ISRCTN
['ISRCTN82388279']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e15845

Informations de copyright

©Margalida Gili, Adoración Castro, Azucena García-Palacios, Javier Garcia-Campayo, Fermin Mayoral-Cleries, Cristina Botella, Miquel Roca, Alberto Barceló-Soler, María M. Hurtado, MªTeresa Navarro, Amelia Villena, M Ángeles Pérez-Ara, Pau Riera-Serra, Rosa Mª Baños. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 05.06.2020.

Références

Aust N Z J Psychiatry. 2018 Sep;52(9):834-846
pubmed: 30052063
J Affect Disord. 2004 Apr;79(1-3):71-9
pubmed: 15023482
BMC Med. 2010 Jun 25;8:38
pubmed: 20579335
BMJ. 2012 Jun 06;344:e2758
pubmed: 22674921
Curr Psychiatry Rep. 2012 Aug;14(4):328-35
pubmed: 22580833
Psychiatr Clin North Am. 2012 Mar;35(1):1-14
pubmed: 22370487
Br J Psychiatry. 2009 Jul;195(1):73-80
pubmed: 19567900
Psychol Med. 2007 Dec;37(12):1797-806
pubmed: 17466110
Gen Hosp Psychiatry. 2004 May-Jun;26(3):184-9
pubmed: 15121346
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
J Clin Psychol. 2009 May;65(5):467-87
pubmed: 19301241
Curr Opin Psychiatry. 2015 Jan;28(1):24-9
pubmed: 25415495
Medicines (Basel). 2018 Nov 02;5(4):
pubmed: 30400211
Psychotherapy (Chic). 2014 Jun;51(2):191-7
pubmed: 24059735
Br J Gen Pract. 2009 Feb;59(559):e51-60
pubmed: 19192368
JMIR Ment Health. 2016 Aug 08;3(3):e37
pubmed: 27502759
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
PLoS One. 2010 Jun 08;5(6):e10939
pubmed: 20544030
J Affect Disord. 2018 Jan 1;225:733-755
pubmed: 28922737
BMC Public Health. 2013 Feb 08;13:119
pubmed: 23390882
J Affect Disord. 2019 Oct 1;257:352-364
pubmed: 31302525
PLoS One. 2014 May 20;9(5):e98118
pubmed: 24844847
J Anxiety Disord. 2018 Apr;55:70-78
pubmed: 29422409
Clin Psychol Rev. 2012 Jun;32(4):329-42
pubmed: 22466510
Int J Psychiatry Med. 2012;43(2):129-51
pubmed: 22849036
Internet Interv. 2018 Mar 07;12:26-35
pubmed: 30135766
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
pubmed: 3397865
Psychol Med. 2012 May;42(5):989-1001
pubmed: 22017808
Can J Psychiatry. 2013 Aug;58(8):442-8
pubmed: 23972105
Psychol Med. 2015 Dec;45(16):3357-76
pubmed: 26235445
J Med Internet Res. 2016 Aug 26;18(8):e231
pubmed: 27565118
Ann Behav Med. 2006 Dec;32(3):254-8
pubmed: 17107299
Gen Hosp Psychiatry. 2009 Jan-Feb;31(1):46-55
pubmed: 19134510
Clin Psychol Rev. 2016 Apr;45:102-14
pubmed: 27111302
J Med Internet Res. 2017 Mar 24;19(3):e90
pubmed: 28341617
Med Clin (Barc). 1999;112 Suppl 1:79-85
pubmed: 10618804
J Affect Disord. 2017 Dec 1;223:28-40
pubmed: 28715726
Lancet. 2012 Dec 15;380(9859):2197-223
pubmed: 23245608
Psychol Med. 2005 Nov;35(11):1633-43
pubmed: 16219121
J Affect Disord. 2006 Nov;96(1-2):9-20
pubmed: 16793140
Psychosom Med. 2001 Jul-Aug;63(4):679-86
pubmed: 11485122
Psychol Sci Public Interest. 2002 Nov;3(2):39-77
pubmed: 26151569
J Consult Clin Psychol. 2010 Apr;78(2):169-83
pubmed: 20350028
PLoS One. 2018 Dec 26;13(12):e0208882
pubmed: 30586371
Med Clin (Barc). 2008 May 24;130(19):726-35
pubmed: 18570798
J Affect Disord. 2019 Feb 15;245:728-743
pubmed: 30447572
J Consult Clin Psychol. 2019 May;87(5):457-471
pubmed: 30998048
JMIR Ment Health. 2018 Sep 25;5(3):e10278
pubmed: 30274963
Health Qual Life Outcomes. 2013 Apr 22;11:66
pubmed: 23607679
J Med Internet Res. 2005 Jun 21;7(2):e16
pubmed: 15998607
BMC Psychiatry. 2015 May 07;15:106
pubmed: 25948287
BMC Fam Pract. 2011 Jun 09;12:47
pubmed: 21658214
BMJ. 2015 Nov 11;351:h5627
pubmed: 26559241
JAMA. 2003 Jun 18;289(23):3095-105
pubmed: 12813115
Clin Psychol Rev. 2018 Jul;63:80-92
pubmed: 29940401

Auteurs

Margalida Gili (M)

Institut Universitari d'Investigació en Ciències de la Salut, University of Balearic Islands, Palma de Mallorca, Spain.
Institut d'Investigació Sanitaria Illes Balears, Palma de Mallorca, Spain.
Primary Care Prevention and Health Promotion Research Network, RedIAPP, Madrid, Spain.

Adoración Castro (A)

Institut Universitari d'Investigació en Ciències de la Salut, University of Balearic Islands, Palma de Mallorca, Spain.
Institut d'Investigació Sanitaria Illes Balears, Palma de Mallorca, Spain.

Azucena García-Palacios (A)

Department of Clinical and Basic Psychology and Biopsychology, Faculty of Health Sciences, Univeristy Jaume I, Castellón, Spain.
Biomedical Research Center Network (CIBER) Physiopathology Obesity and Nutrition (CIBERobn), Carlos III Health Institute, Madrid, Spain.

Javier Garcia-Campayo (J)

Primary Care Prevention and Health Promotion Research Network, RedIAPP, Madrid, Spain.
Departament of Psychiatry, Hospital Miguel Servet, University of Zaragoza, Zaragoza, Spain.

Fermin Mayoral-Cleries (F)

Mental Heath Unit, Hospital Regional of Malaga, Biomedicine Research Institute (IBIMA), Málaga, Spain.

Cristina Botella (C)

Department of Clinical and Basic Psychology and Biopsychology, Faculty of Health Sciences, Univeristy Jaume I, Castellón, Spain.
Biomedical Research Center Network (CIBER) Physiopathology Obesity and Nutrition (CIBERobn), Carlos III Health Institute, Madrid, Spain.

Miquel Roca (M)

Institut Universitari d'Investigació en Ciències de la Salut, University of Balearic Islands, Palma de Mallorca, Spain.
Institut d'Investigació Sanitaria Illes Balears, Palma de Mallorca, Spain.
Primary Care Prevention and Health Promotion Research Network, RedIAPP, Madrid, Spain.

Alberto Barceló-Soler (A)

Aragón Institute for Health Research (IIS Aragon), Zaragoza, Spain.

María M Hurtado (MM)

Mental Heath Unit, Hospital Regional of Malaga, Biomedicine Research Institute (IBIMA), Málaga, Spain.

MªTeresa Navarro (M)

Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.

Amelia Villena (A)

Mental Health Unit of Pozoblaco, Hospital Los Pedroches, Córdoba, Spain.

M Ángeles Pérez-Ara (MÁ)

Institut Universitari d'Investigació en Ciències de la Salut, University of Balearic Islands, Palma de Mallorca, Spain.
Institut d'Investigació Sanitaria Illes Balears, Palma de Mallorca, Spain.

Pau Riera-Serra (P)

Institut Universitari d'Investigació en Ciències de la Salut, University of Balearic Islands, Palma de Mallorca, Spain.
Institut d'Investigació Sanitaria Illes Balears, Palma de Mallorca, Spain.

Rosa Mª Baños (RM)

Biomedical Research Center Network (CIBER) Physiopathology Obesity and Nutrition (CIBERobn), Carlos III Health Institute, Madrid, Spain.
Department of Psychological, Personality, Evaluation and Treatment, University of Valencia, Valencia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH